Profile: Microgen Bioproducts Ltd. develops, manufactures and sells products which are used by laboratory professionals to aid the detection & diagnosis of diseases & organisms which pose a threat to human and animal health. Our product area includes bacteriology, virology, fungal serology, food/envinorment, water, animal health, drug screening, toxicology and immunology/haematology. Our bacteriology product includes diagnostic kits for the identification of bacteria isolated from a broad range of samples routinely submitted to clinical, food, environmental and veterinary laboratories. These products are based on two technology platforms, biochemical identification systems (Microgen™ID) and latex agglutination (Microgen™Latex). Our TOXI-LAB™ AB is a rapid thin layer chromatography based system for the separation, detection and identification of various substances, including drugs, in urine. The ToxiLab™ drug detection system can be used in hospital, reference and forensic laboratories to screen for the presence of drugs &other substances.
The company has revenues of USD 5-10 Million, has ~30 employees and is ISO 9001, ISO13485 certified.
FDA Registration Number: 1000234991
US Agent: John Belistreri / John Belistreri
Phone: +1-(830)-562-3001 Fax: +1-(858)-712-2102 E-Mail:
16 Products/Services (Click for related suppliers)
|
• Adenovirus 1-33 CF Antisera (FDA Code: GOA / 866.3020) Adenovirus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to adenovirus in serum. Additionally, some of these reagents consist of adenovirus antisera conjugated with a fluorescent dye and are used to identify adenoviruses directly from clinical specimens. The identification aids in the diagnosis of disease caused by adenoviruses and provides epidemiological information on these diseases. Adenovirus infections may cause pharyngitis (inflammation of the throat), acute respiratory diseases, and certain external diseases of the eye (e.g., conjunctivitis). |
• Aspergillus Spp CF Antigen (FDA Code: JWT / 866.3040) |
• Clostridium Difficile Antigen (FDA Code: MCB / 866.2660) A microorganism differentiation and identification device is a device intended for medical purposes that consists of one or more components, such as differential culture media, biochemical reagents, and paper discs or paper strips impregnated with test reagents, that are usually contained in individual compartments and used to differentiate and identify selected microorganisms. The device aids in the diagnosis of disease. |
• Enterobacteriaceae Identification Kit (FDA Code: JSS / 866.2660) |
• Enzyme Immunoassay Test |
• Escherichia Coli Antisera (FDA Code: GNA / 866.3255) |
• Legionella Direct & Indirect Fluorescent Antibody Regents (FDA Code: LHL / 866.3300) |
• Microorganism Differentiation Strip and Reagent Disc (FDA Code: JTO / 866.2660) |
• Radial Immunodiffusion Plates and Equipment (FDA Code: JZQ / 866.4800) A radial immunodiffusion plate for clinical use is a device that consists of a plastic plate to which agar gel containing antiserum is added. In radial immunodiffusion, antigens migrate through gel which originally contains specific antibodies. As the reagents come in contact with each other, they combine to form a precipitate that is trapped in the gel matrix and immobilized. |
• Reticulocyte Stain (FDA Code: GJH / 864.1850) Dye and chemical solution stains for medical purposes are mixtures of synthetic or natural dyes or nondye chemicals in solutions used in staining cells and tissues for diagnostic histopathology, cytopathology, or hematology. |
• Rotavirus Enzyme Linked Immunoabsorbent Assay (FDA Code: LIQ / 866.3405) Poliovirus serological reagents are devices that consist of antigens and antisera used in serological tests to identify antibodies to poliovirus in serum. Additionally, some of these reagents consist of poliovirus antisera conjugated with a fluorescent dye (immunofluorescent reagents) used to identify polioviruses from clinical specimens or from tissue culture isolates derived from clinical specimens. The identification aids in the diagnosis of poliomyelitis (polio) and provides epidemiological information on this disease. Poliomyelitis is an acute infectious disease which in its serious form affects the central nervous system resulting in atrophy (wasting away) of groups of muscles, ending in contraction and permanent deformity. |
• Salmonella Spp Antiserum (FDA Code: GRM / 866.3550) |
• Staphylococcus Aureus Screening Kit (FDA Code: JWX / 866.2660) |
• Staphylococcus Spp Fluorescent Antisera (All Types) (FDA Code: GTN / 866.3700) |
• Streptococcus Spp Antiserum (FDA Code: GTZ / 866.3740) |
• Whole Blood Plasma (FDA Code: DGQ / 866.5700) A whole human plasma or serum immunological test system is a device that consists of reagents used to measure by immunochemical techniques the proteins in plasma or serum. Measurements of proteins in plasma or serum aid in the diagnosis of any disease concerned with abnormal levels of plasma or serum proteins, e.g., agammaglobulinemia, allergies, multiple myeloma, rheumatoid vasculitis, or hereditary angioneurotic edema. |